Most pain management revenue problems are policy problems, not coding problems: injections exceeding a payer's per-region frequency limit, radiofrequency claims billed without the documented functional improvement payers require for coverage, and image guidance billed separately on codes where CMS bundled it years ago.
Start with frequency. Payers commonly limit epidural steroid injections to a specified number per spinal region over a rolling 12-month period, and require documented pain and functional improvement between treatments. Those limits are payer-specific and enforced at authorization and at payment — so the billing discipline begins before the procedure is scheduled, with an authorization date and the prior treatment history attached.
Next, guidance bundling. CMS bundles fluoroscopic image guidance (77003) into common interlaminar and transforaminal epidural code families; claims that still bill guidance separately on those services deny under NCCI and, worse, flag the account for review. Our scrubbing layer applies the current bundling table per code pair, so guidance is billed only where it remains separately payable.
Finally, radiofrequency ablation. Codes like 64635–64636 carry documentation thresholds — confirmed diagnostic blocks, degree of relief, and target-nerve identification — that payers check line by line. We assemble the evidence packet at authorization, so the same documentation drives both the approval and the payable claim.
“48% of leaders named denials and appeals their practice’s largest source of revenue leakage, compared with 23% who cited front-end issues.”